Resultados de la búsqueda 141-150 of 1034 for Alternative

1. Salud de los consumidores Consumer health basics - Mayo Clinic

   Complementary, alternative, or integrative health: What's in a name? National Center for Complementary and Integrative Medicine. https://nccih.nih.gov ...

2. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   Finally, it will allow characterization of patient selection factors and processes for ticagrelor vs alternative OAP agents, carrying out that descriptive ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

4. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   Finally, it will allow characterization of patient selection factors and processes for ticagrelor vs alternative OAP agents, carrying out that descriptive ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Intraoperative blood salvage is a relatively safe and cost-effective alternative to allogeneic blood transfusion during procedures with large volume blood loss.

6. Medicina integral y salud - Médicos - Mayo Clinic

   Complementary, alternative, or integrative health: What's in a name? National Center for Complementary and Integrative Health. National Institutes of Health ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Intraoperative blood salvage is a relatively safe and cost-effective alternative to allogeneic blood transfusion during procedures with large volume blood loss.

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

9. Hematología - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...